Form 4 Tracker
LIGAND PHARMACEUTICALS INC
LGND

36 insider filings · Latest: Aug 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 12, 2026May 15 1:08 AMJohn W KozarichDirector
Sale
459$224.00$102.8K41,786(D)

View →

May 1, 2026May 15 1:08 AMJohn W KozarichDirector
Sale
467$231.80$108.3K41,786(D)

View →

May 13, 2026May 13 8:09 PMJOHN KOZARICH
Proposed Sale
1,575$223.50$352.0K

View →

May 12, 2026May 12 9:45 PMJOHN KOZARICH
Proposed Sale
459$224.00$102.8K

View →

May 1, 2026May 5 12:20 AMAndrew ReardonCLO & Secretary
Sale
5,000$231.31$1.2M41,382(D)

View →

May 1, 2026May 1 8:16 PMKOZARICH JOHN W
Proposed Sale
467$229.87$107.3K

View →

Apr 1, 2026Apr 2 11:43 PMJohn W KozarichDirector
Sale
467$202.23$94.4K42,253(D)

View →

Apr 1, 2026Apr 2 10:56 PMAndrew ReardonCLO & Secretary
Sale
5,000$201.24$1.0M41,382(D)

View →

Apr 1, 2026Apr 1 8:10 PMKOZARICH JOHN W
Proposed Sale
467$203.50$95.0K

View →

Mar 6, 2026Mar 31 9:53 PMJohn L LamattinaDirector
Sale
2,161$200.76$433.8K30,724(D)

View →

Mar 23, 2026Mar 25 3:13 PMStephen L SabbaDirector
Sale
1,000$207.87$207.9K32,793(D)

View →

Mar 23, 2026Mar 23 8:04 PMSTEPHEN L. SABBA
Proposed Sale
1,000$207.87$207.9K

View →

Mar 11, 2026Mar 13 11:29 PMOctavio EspinozaChief Financial Officer
Sale
3,057$225.00$687.8K21,010(D)

View →

Mar 11, 2026Mar 11 8:42 PMOCTAVIO ESPINOZA
Proposed Sale
3,057$212.29$649.0K

View →

Mar 4, 2026Mar 6 11:51 PMAndrew ReardonCLO & Secretary
Sale
5,000$206.35$1.0M36,869(D)

View →

Mar 4, 2026Mar 6 11:49 PMOctavio EspinozaChief Financial Officer
Sale
13,423$205.83$2.8M21,662(D)

View →

Mar 6, 2026Mar 6 9:17 PMJOHN L LAMATTINA
Proposed Sale
2,161$200.76$433.8K

View →

Mar 3, 2026Mar 5 4:05 PMStephen L SabbaDirector
Sale
2,034$201.50$409.9K33,793(D)

View →

Mar 2, 2026Mar 5 2:04 AMJohn W KozarichDirector
Sale
467$200.50$93.6K42,720(D)

View →

Mar 4, 2026Mar 4 9:44 PMANDREW REARDON
Proposed Sale
20,000$204.24$4.1M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 12, 2026Aug 14 9:05 PMOctavio EspinozaChief Financial Officer
Option Exercise
31,641$70.040(D)

View →

Aug 12, 2026Aug 14 9:04 PMJason HaasDirector
Option Exercise
6,138$51.560(D)

View →

Aug 3, 2026Aug 4 10:42 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2729,444(D)

View →

Jul 1, 2026Jul 6 9:11 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2734,444(D)

View →

Jun 16, 2026Jun 18 12:37 PMStephen L SabbaDirector
Option Exercise
2,145$66.130(D)

View →

Jun 12, 2026Jun 16 1:06 AMJason HaasDirector
Option Exercise
4,000$51.566,138(D)

View →

Jun 5, 2026Jun 12 9:27 PMJason AryehDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:42 PMMartine ZimmermannDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:41 PMStephen L SabbaDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:41 PMJohn L LamattinaDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:40 PMJohn W KozarichDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:35 PMJason HaasDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:35 PMNancy Ryan GrayDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 1, 2026Jun 2 10:22 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2739,444(D)

View →

May 27, 2026May 28 11:43 PMOctavio EspinozaChief Financial Officer
Option Exercise
1,736$63.6217,407(D)

View →

May 13, 2026May 15 1:08 AMJohn W KozarichDirector
Option Exercise
1,575$69.510(D)

View →

May 12, 2026May 15 1:08 AMJohn W KozarichDirector
Option Exercise
459$69.511,575(D)

View →

May 1, 2026May 5 12:20 AMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2744,444(D)

View →

Apr 1, 2026Apr 2 10:56 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2749,444(D)

View →

Mar 6, 2026Mar 31 9:53 PMJohn L LamattinaDirector
Option Exercise
2,161$114.150(D)

View →

Page 1 of 2

Next →